Hemoglobin HbA1c (A1c) has been used clinically since the 1980s as a test of glycemic
control in individuals with diabetes. The Diabetes Control and Complications Trial (DCCT) …

Anemia is more common in patients with diabetes than without diabetes, and the problem is
magnified in patients with renal impairment. Diabetic patients with anemia may be at …

Measurement of glycohemoglobin (GHb) is an integral component of the management of
patients with diabetes mellitus (1, 2). Glycation is the nonenzymatic addition of a sugar …

Background Previous studies have shown no correlation between adhesive capsulitis and
hemoglobin A 1c (HbA 1c). However, HbA 1c is only a measure of short-term blood sugar …

Background and aims The concentration of glycated hemoglobin (HbA1c) is an essential
diagnostic and therapeutic biomarker in diabetes mellitus. However, it is known that Hb …

Background: There is controversy regarding the influence of glycemic control in diabetic
patients with frozen shoulder. To determine the relationship between glycemic control and …

Aims: To identify the causes of very low glycohaemoglobin (GHb) values in a sample of
patients with diabetes in southern Brazil using high performance liquid chromatography …

The prevalence of diabetes in population and type 2 diabetes is particular, has reached
epidemic proportions worldwide. The HbA1c test is currently one of the best ways to …

Glycated hemoglobin is widely used in the management of diabetes mellitus. At least
300,000 Americans with diabetes mellitus have the hemoglobin (Hb) C or S trait. The …

Glycohemoglobin (gHb) is a biochemical marker of longterm glycemic control that is highly
correlated with complications of diabetes mellitus (1). The presence of hemoglobin (Hb) …